A photo of Joel Mortensen.

Director, Diagnostic Infectious Diseases Testing Laboratory (Microbiology and Virology)

Professor, UC Department of Pediatrics

513-636-5310

513-636-8850

My Biography & Research

Biography

My research interests involve developing testing methods for infectious diseases via clinical research trials. The type of goals my colleagues and I are attempting to reach through our research is to reduce the time it takes to detect infectious diseases as well as improve the sensitivity and specificity of diagnostic testing by applying cutting-edge technologies.

The patient care I specialize in involves diagnostic testing for infectious diseases. I was inspired to become a healthcare provider and work with children through a deep personal identification with this particular mission.

I have provided direction to the diagnostic laboratory to ensure the highest quality of results for our patients and I have provided consultation services to the healthcare staff in clinical microbiology. I’ve pursued expanding rapid testing approaches in a clinical microbiology laboratory and in outpatient settings.

I have more than 30 years of clinical microbiology experience and first joined the team at Cincinnati Children’s in 1991. In collaboration with faculty and fellows at Cincinnati Children’s Hospital, I have participated in more than 100 peer-reviewed publications, text chapters and case studies. Our research has been published in numerous respected journals, such as Diagnostic Microbiology and Infectious Disease, Journal of Clinical Microbiology, The Pediatric Infectious Disease Journal, and Pediatric Quality and Safety.

Clinical Interests

Application of rapid testing methods into the clinical microbiology laboratory and outpatient settings; LEAN manufacturing processes applied to clinical microbiology.

Research Interests

Antimicrobial susceptibility testing of fastidious pediatric pathogens.

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Pathology

Research Divisions

Pathology

My Education

BS: Mount Union College, Alliance, OH, 1979.

PhD: The Ohio State University, Columbus, OH, 1983.

Residency: Accredited Postdoctoral Residence Program in Medical and Public Health Microbiology; Baylor College of Medicine, University of Texas Medical School, Pathology, Houston, TX, 1983-85.

Certification: Certified Laboratory Consultant, American Medical Technologists, 1998.

My Publications

Chlamydia conjunctivitis in 2 prepubertal children: An uncommon presentation of child sexual abuse. Brownell, AD; Utz, VM; Makoroff, KL; Shapiro, RA; Mortensen, JE. Pediatric Emergency Care. 2020; Publish Ahead of Print:e473-e475.

Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections. Powell, EA; Khalil, N; Deburger, B; Mortensen, JE. Microbial Drug Resistance: mechanism, epidemiology, and disease. 2020; 26:825-830.

AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria. McDaniel, CT; Panmanee, W; Winsor, GL; Gill, E; Bertelli, C; Schurr, MJ; Dongare, P; Paul, AT; Ko, SB; Lau, GW; et al. Proceedings of the National Academy of Sciences of USA. 2020; 117:4921-4930.

Multilab evaluation of delafloxacin MIC Test Strip against Gram-negative and Gram-positive organisms. Koeth, LK; DiFranco-Fisher, JM; Hardy, DJ; Mortensen, JE; Palavecino, E; Windau, AW. Diagnostic Microbiology and Infectious Disease. 2019; 95:114868-114868.

Multicenter clinical validation of the molecular BD max enteric viral panel for detection of enteric pathogens. Stokes, W; Simner, PJ; Mortensen, J; Oethinger, M; Stellrecht, K; Lockamy, E; Lay, T; Bouchy, P; Pillai, DR. Journal of Clinical Microbiology. 2019; 57.

Association of systemic antimicrobials with the expression of beta-lactamases in bacteria cultured from urological patients. Forster, CS; Powell, EA; DeBurger, B; Courter, J; Haslam, DB; Mortensen, JE. Diagnostic Microbiology and Infectious Disease. 2019; 94:391-394.

Neonatal bacteremia and oligoarthritis caused by Rhodococcus corynebacterioides/Rhodococcus kroppenstedtii. Khalil, N; Corker, L; Powell, EA; Mortensen, JE. Diagnostic Microbiology and Infectious Disease. 2019; 94:395-397.

Successful Whole Genome Sequencing-guided Treatment of Mycoplasma hominis Ventriculitis in a Preterm Infant. Huang, FA S; Mortensen, J; Skoch, J; Andersen, H; Staat, MA; Schaffzin, JK; Haslam, DB. The Pediatric Infectious Disease Journal. 2019; 38:749-751.

Accelerating Initiation of Adequate Antimicrobial Therapy Using Real-Time Decision Support and Microarray Testing. Tchou, MJ; Andersen, H; Robinette, E; Mortensen, JE; Powell, EA; Ankrum, A; Washam, MC; Haslam, DB; Courter, JD. Pediatric Quality and Safety. 2019; 4:e191-e191.

Reliability of the Verigene system for the identification for Gram-positive Bacteria and detection of antimicrobial resistance markers from children with bacteremia. Beckman, M; Washam, MC; DeBurger, B; Haslam, DB; Courter, JD; Andersen, H; Schaffzin, JK; Tchou, MJ; Ankrum, A; Mortensen, J. Diagnostic Microbiology and Infectious Disease. 2019; S0732:30474-30477.